|Year : 2022 | Volume
| Issue : 4 | Page : 580-582
HBE homozygous haemoglobinpathy – Fortuitous finding
VL Premika Sri, C Sreeja, R Sathish Muthukumar, N Nachiammai, Merlin Jayaraj, AH Harini Priya
Department of Oral and Maxillofacial Pathology, Chettinad Dental College and Research Institute, Chennai, Tamil Nadu, India
|Date of Submission||22-Feb-2022|
|Date of Decision||13-Apr-2022|
|Date of Acceptance||25-Apr-2022|
|Date of Web Publication||22-Dec-2022|
Reader, Room no. 5B, Department of Oral and Maxillofacial Pathology, Chettinad Dental College and Research Institute, Rajiv Gandhi Salai, Kelambakkam, Chennai - 603103, Tamil Nadu
Source of Support: None, Conflict of Interest: None
| Abstract|| |
A 24-year-old male patient presented with the principal complaint of deposits on his teeth and gingival pigmentation. After examination, he was diagnosed with chronic generalized gingivitis. He was further referred for pre-procedural routine blood investigations. Bleeding time, clotting time, and his random blood sugar values were normal. CBC report revealed the presence of erythrocytosis with microcytic hypochromic red blood cells. Following this peripheral smear was taken which reveals the presence of polychromatophils, target cells and a few spherocytes. Haemoglobin electrophoresis by high-performance liquid chromatography (HPLC) was performed which disclosed 90.8% of HbE, suggestive of homozygous haemoglobinopathy. He had no other associated systemic findings, and there was no relevant family history.
The patient was informed about his condition and stated to have pre-marital and pre-natal genetic counselling in the future. The patient being a carrier of the thalassaemic trait happened to know his condition incidentally, which could prevent future complications.
Keywords: Codocytes, hemoglobinopathy, thalassemic trait
|How to cite this article:|
Premika Sri V L, Sreeja C, Muthukumar R S, Nachiammai N, Jayaraj M, Harini Priya A H. HBE homozygous haemoglobinpathy – Fortuitous finding. J Oral Maxillofac Pathol 2022;26:580-2
|How to cite this URL:|
Premika Sri V L, Sreeja C, Muthukumar R S, Nachiammai N, Jayaraj M, Harini Priya A H. HBE homozygous haemoglobinpathy – Fortuitous finding. J Oral Maxillofac Pathol [serial online] 2022 [cited 2023 Feb 3];26:580-2. Available from: https://www.jomfp.in/text.asp?2022/26/4/580/364831
| Introduction|| |
Extensive knowledge about systemic disease and their investigations is obligatory for the dentist to promote general health, educate the patient as well as prevent future complications. This case report describes the incidental finding of haemoglobinopathy in an asymptomatic patient, with no family history be useful in precluding the complications to the next generation by taking pre-natal genetic counselling. Haemoglobinopathies encompass inherited disorders of the protein component of haemoglobin (Hb, i.e., the globin chain). Specific populations are particularly at high threat of having a haemoglobinopathy, for example, in Southeast Asia, sub-Saharan Africa and the West Pacific region.
| Case Report|| |
A 24-year-old healthy constructional worker with no anomalous family history was referred to the oral pathology department for his routine blood examinations. He had presented with the complaint of deposits on his tooth and also had the complaint of gingival pigmentation which bothered him aesthetically. He did not have any other relevant medical history or deleterious habits. On intra-oral examination, stains and calculus were seen along with the presence of a few carious teeth.
Routine blood investigations were performed which revealed the bleeding time of about 1 minute 14 seconds, clotting time of 3 minutes 24 seconds and random blood sugar of 92 mg/dl. Complete blood count examinations [Figure 1] were done which reported the drop in level of mean corpuscular volume of about 69.5FL (ref range -80–100 FL), mean corpuscular haemoglobin of 22 g (ref range-27–32 PG), mean corpuscular haemoglobin concentration of 31.6G/DL (ref range-33–38 G/DL) and red blood cell distribution width of 18.1% (ref range -11.6–14%).
A peripheral smear [Figure 2] was taken for this patient to look into the structure of RBCs which revealed the presence of polychromatophils, numerous target cells, crowding of red blood cells, and few spherocytes. He was then advised for haemoglobin electrophoresis by the HPLC method. HbE report [Figure 3] and [Figure 4] showed the foetal haemoglobin (HbF) value of 3.3% (ref range – 0–2), haemoglobin A2(HbA2) of 5.1% (ref range -2.2–3.5), haemoglobin D (HbD) of 0.8% (ref range – 0–0) and haemoglobin E (HbE) of 90.8% (ref range – 0–0). Skull posteroanterior view was taken which revealed no abnormality.
|Figure 2: Peripheral smear showing RBC crowding, and the blue arrow indicates the target cells with their characteristic bull's eye appearance|
Click here to view
|Figure 3: Haemoglobin electrophoresis estimation by high-performance liquid chromatography|
Click here to view
The patient being asymptomatic with no incidence of disease in his family lineage was advised to have pre-marital and pre-natal genetic counselling for screening of genetic disorders which can be transmitted through him to his offspring in the future.
| Discussion|| |
Haemoglobin within the erythrocytes is crucial for the existence, transportation of oxygen to the tissues. The inherited disorders of haemoglobin, notably sickle cell disease, thalassaemia and haemoglobin E disorders, are the most common monogenic disorders globally with the autosomal recessive pattern as the mode of inheritance. Approximately 7% of the population are carriers of haemoglobinopathies including thalassaemia, haemoglobin (Hb) E and HbS, and 300,000–500,000 children are born annually with a severe haemoglobin disorder, the majority of them in developing countries. Chernoff and colleagues reported the first case in 1954.
HbE is the most common haemoglobin variant in Southeast Asia as well as in Northeast India. HbE is thalassaemic haemoglobinopathies having structurally abnormal HbE. HbE is variant haemoglobin with a spontaneous mutation in nuclear DNA, which can be a point mutation involving alteration of a single nucleotide or otherwise deletion, insertion or other alteration in more than one nucleotide.,
The so-called -globinopathies (-thalassemia major, sickle cell syndromes and Hb E-thalassemia) generally present a greater global health burden than the a-thalassemia syndromes. Patients with severe -globinopathies require life-long treatment and clinical management. HbE present in three forms, heterozygous state Hb E trait, homozygous Hb E disease, and most important compound heterozygous Hb E/βthalassemia or Hb E sickle cell anaemia. The biogenesis of structural variants is generally normal except for hemoglobinopathies caused by mutation in -fusion genes (Lepore haemoglobin) or in the -globin chain termination codon (Constant Spring haemoglobins). Thalassemia result from disruption of the standard coordinated synthesis of the globin chains that encompass tetrameric haemoglobin. The thalassemia phenotype includes combinations and varying degrees of hypochromia and microcytosis, anaemia, splenomegaly, reticulocytosis and erythroid bone marrow hyperplasia.
The diagnosis of disorders of haemoglobin chain synthesis usually involves a combination of tests along with detailed clinical history, ethnic background, blood count and peripheral blood film examination. Patients suffering from HbE disease present with chronic anaemia without splenomegaly; blood count often resembles the β-thalassaemia trait which is seen in our case., HbE is an extremely common Hb variant with a disease pattern similar to that of β-thalassaemia. Haemolysis can be caused by viral infections and medications due to the presence of unstable Hb. HbE is often associated with thalassaemia, which may result in serious major-form haemoglobinopathies. HbE homozygosity (HbE disease is moderate with microcytic hypochromic anaemia) with possible haemolysis due to exogenous causes which are observed in our case.
The objective of pre-natal haemoglobinopathy screening is to detect and counsel asymptomatic individuals whose offspring are at risk of thalassaemia major/intermedia which was advised to our patient. This comprises universal screening during early pregnancy by complete blood count examination and peripheral smear examination. Any abnormality detected in these tests would further be evaluated and confirmed by HPLC. This is followed by the screening of partners and genetic counselling. Pre-natal diagnosis by chorionic villus sampling (amniocentesis) is to be done.,
Haemoglobinopathy can be prevented by assessing the carrier status of the couples in the early stages of pregnancy with the help of carrier testing by complete blood count examination and haemoglobin electrophoresis by HPLC. Abnormal Hb variants can interact with thalassaemia trait to give rise to thalassaemia major/intermedia or can be clinically silent. It is essential requisite for dentist to know about these haematological disorders so as to educate patients and to promote their oral health and general health as well.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Trent RJ. Diagnosis of the haemoglobinopathies. Clin Biochem Rev 2006;27:27–38.
Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders. Expert Rev Hematol 2010;3:103-17.
Karthika M, Devi KG, Rymbui DB, Bhardwaj P, Ao S, Kumar S. Prevalence of hemoglobinopathies in Manipur. IOSR J Dent Med Sci 2012;14:P17-20.
Jha BM, Bhavna G, Jitendra P, Prajapati KJ. Hemoglobin E disorders in South Gujarat: A study of 35 cases. Nat J Comm Med 2012;3:66-70.
Steinberg MH, Adams JG. Thalassemic hemoglobinopathies. Am J Pathol 1983;113:396-409.
Agarwal A. A case report on HBE homozygous haemoglobinopathy. Int J Recent Sci Res 2015;6:5840-2.
Kohne E. Hemoglobinopathies: Clinical manifestations, diagnosis, and treatment. Deutsches Ärzteblatt Int 2011;108:532-40.
Thakur S, Singh S. Genetic counseling to prevent thalassemia and hemoglobinopathy in the Indian Population. 2019.
Traeger-Synodinos J, Harteveld CL. Advances in technologies for screening and diagnosis of hemoglobinopathies. Biomark Med 2014;8:119-31.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]